Another disease caused by a mutation in a single gene is Huntington’s disease (HD), an autosomal...

Another disease caused by a mutation in a single gene is Huntington’s disease (HD), an autosomal dominant condition. It is caused by mutations in a gene required for normal nerve cell function. The mutations cause abnormal proteins to be produced which “stick” together and accumulate in nerve cells, eventually interfering with normal cell operations. Suggest two ways you could treat the disease by targeting the translation step for the HD protein and justify why each approach might be effective.

Solutions

Expert Solution

We can approach with the steps which can inhibit the production of abnormal protein. There are two approved method which shows some effective results.

Method 1

AMT-130 is an experimental gene therapy that works by inhibiting the production of the mutated forms of the huntingtin (mHTT) protein, the underlying cause of Huntington’s disease.

The therapy is composed of a small portion of synthetic genetic material called microRNA, that, once inside the cell, binds to and destroys the molecule carrying the genetic information for the production of the huntingtin protein. As a result, AMT-130 decreases production of the abnormal mHTT protein.

Method 2

We can use induced pluripotent stem cells (iPSC) of Huntington’s patients to generate neurons. Of note, IPSCs are derived from either skin or blood cells that have been reprogrammed back into a stem cell-like state, which allows for the development of an unlimited source of almost any type of human cell.

AMT-130 treated iPSC-derived neurons released EVs filled with microRNA targeting huntingtin (miHTT) in a dose-dependent manner. The therapy also lowered the levels of mHTT.

Notably, microRNAs are tiny RNA molecules that control the expression of several genes; gene expression is the process by which information in a gene is synthesized to create a working product, such as a protein.

The therapy has shown promising results in preclinical studies and has been granted orphan drug status and fast track designation by the U.S. Food and Drug Administration (FDA).

gladiator answered 1 year ago

Next > < Previous

Related Solutions

The Huntington’s Disease (HD) gene (HTT) is located on chromosome 4, and the age of onset...

The Huntington’s Disease (HD) gene (HTT) is located on chromosome 4, and the age of onset of the condition is closely related to the repeat-expansion size within this gene. Recent research shows that a particular variant on chromosome 15 acts as a modifier for the condition. Someone with a repeat expansion in their HTT gene as well as this modifier variant will develop HD symptoms approximately six years earlier than someone without this modifier variant. A woman with Huntington’s disease...

Huntington’s disease (HD) is a fatal neurodegenerative disorder. As the disease progresses, HD patients exhibit abnormalities...

Huntington’s disease (HD) is a fatal neurodegenerative disorder. As the disease progresses, HD patients exhibit abnormalities in both of their efferent motor divisions. Interestingly, HD patients seem to have impairments in their ability to regulate Mean Arterial Pressure. For example, you are treating a patient who always gets lightheaded and/or faints immediately upon standing. The issue is so pronounced that they literally sleep standing up! (a) (2 points) What change in MAP occurs for someone who stands up? Please use...

If there is an affected heterozygous parent with Huntington’s disease (an autosomal dominant disease) who has...

If there is an affected heterozygous parent with Huntington’s disease (an autosomal dominant disease) who has children with an unaffected parent, what are the chances of them having kids with Huntington’s disease? If there are two parents who are heterozygous carriers for Cystic Fibrosis disease (an autosomal recessive disease) What are the chances of them having a child with Cystic Fibrosis disease? What are the chances of them having a child who is a carrier for Cystic Fibrosis? What are...

Cystic fibrosis is caused by a mutation in a single gene. Homozygotes for this mutant recessive...

Cystic fibrosis is caused by a mutation in a single gene. Homozygotes for this mutant recessive allele (ff) have cystic fibrosis. Within a population, 2% of people have cystic fibrosis. Assuming Hardy-Weinberg equilibrium, the frequency of heterozygotes in the population is 0.24. If inbreeding was common in this population, what would happen to the percentage of people who have cystic fibrosis over time?

HUNTINGTON’S DISEASE is an autosomal dominantly inherited, degenerative human disease of the nervous system. Individuals homozygous...

HUNTINGTON’S DISEASE is an autosomal dominantly inherited, degenerative human disease of the nervous system. Individuals homozygous for this dominant gene almost always die as a fetus. The disease has no obvious phenotypic effects in a heterozygous individual, until a person is about 35-40 years old, well into child-rearing years. There is no known cure for this genetic disease. E. Determine the results of a mating between two parents, both of whom will get Huntington’s disease. Provide the Punnett square and...

1)Cystic fibrosis an autosomal recessive disorder caused by a single gene, affects the lungs, the pancreas,...

1)Cystic fibrosis an autosomal recessive disorder caused by a single gene, affects the lungs, the pancreas, the digestive system, and other organs, resulting in symptoms ranging from breathing difficulties to recurrent infections. Which of the following terms best describes this? A)incomplete dominance B)multiple alleles C)codominance D)epistasis E)pleiotropy 2)What is one function of a signal peptide during peptide translation? A)to terminate translation of the messenger RNA B)to signal the initiation of transcription C)to bind RNA polymerase to DNA and initiate transcription...

The disease Leber congenital amaurosis (LCA) caused by loss-of-function mutation of a gene called RPE65, has...

The disease Leber congenital amaurosis (LCA) caused by loss-of-function mutation of a gene called RPE65, has been treated with gene therapy by injecting recombinant AAV vectors containing a normal copy of the RPE65 gene into their retinal epithelial cells. Patients receiving this therapy: May need to repeat the treatment as the viral DNA is degraded May acquire detrimental mutations due to integration of the virus Will pass the mutation to their offspring Now have the normal RPE65 gene Pharming refers...

Retinitis pigmentosa, a form of blindness in humans, may be caused by a dominant autosomal gene,...

Retinitis pigmentosa, a form of blindness in humans, may be caused by a dominant autosomal gene, R, or a recessive autosomal gene, a. Thus only A_ rr individuals have normal sight. An afflicted man whose parents are both normal marries a woman of genotype AaRr. (A) What is the genotype of the afflicted man? (B) What proportion of the children are expected to suffer from this affliction if R and A map to different chromosomes?

Sickle cell anemia is a recessive disorder caused by a mutation in the hemoglobin A gene....

Sickle cell anemia is a recessive disorder caused by a mutation in the hemoglobin A gene. Persons with the disease have a variety of serious health issues related to fragile and sickling red blood cells including premature death, and infants sometimes die from complications. In regions of central Africa where malaria is endemic, the relative fitnesses for individuals that are homozygous for the wild type hemoglobin allele (HbA), heterozygous (HbAHbS), and homozygous for the sickle cell allele (HbS) are 0.8,...

Assuming Hardy-Weinberg conditions are met: a rare disorder is caused by an autosomal recessive mutation. Calculate...

Assuming Hardy-Weinberg conditions are met: a rare disorder is caused by an autosomal recessive mutation. Calculate the percentage of heterozygous carriers in a population if the disease affects 1 in 15,000 individuals (show your work).

Subjects